You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Asthma
 •Quality of Life
 •Allergy
 •Randomized Controlled Trial
 •Treatment Adherence
 •Pediatrics, Other
 •Drug Therapy
 •Alert me on articles by topic

Benefits of a School-Based Asthma Treatment Program in the Absence of Secondhand Smoke Exposure

Results of a Randomized Clinical Trial

Jill S. Halterman, MD, MPH; Peter G. Szilagyi, MD, MPH; H. Lorrie Yoos, PhD; Kelly M. Conn, BS; Jeffrey M. Kaczorowski, MD; Robert J. Holzhauer, MD, MBA; Sherri C. Lauver, PhD; Tia L. Neely, BA; Patrick M. Callahan, BM; Kenneth M. McConnochie, MD, MPH

Arch Pediatr Adolesc Med. 2004;158:460-467.

Background  Daily maintenance medications are recommended for all children with mild persistent to severe persistent asthma; however, poor adherence to these medications is common.

Objective  To evaluate the impact of school-based provision of inhaled corticosteroids on asthma severity among urban children with mild persistent to severe persistent asthma.

Design  Children aged 3 to 7 years with mild persistent to severe persistent asthma were identified at the start of the 2000-2001 and 2001-2002 school years in Rochester. Children were assigned randomly to a school-based care group (daily inhaled corticosteroids provided through the school) or a usual-care group (inhaled corticosteroids not given through school).

Main Outcome Measure  Improvement in parent-reported symptom-free days.

Results  Of 242 eligible children, 184 were enrolled from 54 urban schools. Data for 180 children were available. Parents of children in the school-based care group had a greater improvement in quality of life compared with parents of children in the usual-care group (change score, 0.63 vs 0.24; P = .047); also, children in the school-based care group vs the usual-care group missed less school because of asthma (mean total days missed, 6.8 vs 8.8; P = .047) and experienced more symptom-free days during the early winter months (mean days per 2-week period, 9.2 vs 7.3; P = .02). A post hoc analysis revealed that all significant findings were produced by differences among children who were not exposed to secondhand smoke. Furthermore, among children not exposed to smoke, those in the school-based care group vs the usual-care group had more symptom-free days overall (11.5 vs 10.5; P = .046), had fewer days needing rescue medications (1.6 vs 2.3; P = .03), and were less likely to have had 3 or more acute visits for asthma (6 [13%] of 47 children vs 17 [31%] of 54 children; P = .03).

Conclusions  School-based provision of inhaled corticosteroids significantly improved symptoms, quality of life, and absenteeism among urban children with mild persistent to severe persistent asthma. This effect was seen only among children not exposed to secondhand smoke.


From the Department of Pediatrics, University of Rochester School of Medicine and Dentistry and the Strong Children's Research Center, Rochester, NY (Drs Halterman, Szilagyi, Kaczorowski, Holzhauer, and McConnochie, Mss Conn and Neely, and Mr Callahan); the School of Nursing, University of Rochester School of Medicine and Dentistry (Dr Yoos); and the Graduate School of Education, University of Pennsylvania, Philadelphia (Dr Lauver).


RELATED ARTICLE

Interpreting Subgroup Analyses: Is a School-Based Asthma Treatment Program's Effect Modified by Secondhand Smoke Exposure?
David G. Bundy, Molly Curtin Berkoff, Kristin E. Ito, Marjorie S. Rosenthal, and Morris Weinberger
Arch Pediatr Adolesc Med. 2004;158(5):469-471.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Treating patients with respiratory disease who smoke
Braganza et al.
Therapeutic Advances in Respiratory Disease 2008;2:95-107.
ABSTRACT  

A controlled trial of a school-based intervention to improve asthma management
McCann et al.
Eur Respir J 2006;27:921-928.
ABSTRACT | FULL TEXT  

Improved Asthma Care After Enrollment in the State Children's Health Insurance Program in New York
Szilagyi et al.
Pediatrics 2006;117:486-496.
ABSTRACT | FULL TEXT  

The Crucial Role of the Vanishing School Nurse
Chamberlain and Bauer
Arch Pediatr Adolesc Med 2004;158:1091-1091.
FULL TEXT  

23 Apr 2004 to 23 Jul 2004
Evid. Based Nurs. 2004;7:e4-e4.
FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:e5-e5.
FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:159-160.
FULL TEXT  

Interpreting Subgroup Analyses: Is a School-Based Asthma Treatment Program's Effect Modified by Secondhand Smoke Exposure?
Bundy et al.
Arch Pediatr Adolesc Med 2004;158:469-471.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.